54 results
6-K
EX-99.1
BYSI
BeyondSpring Inc
23 Nov 22
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
4:30pm
of clinical trials, delays or denial in regulatory approval process, results that do not meet the Company’s expectations regarding the potential safety
6-K
EX-99.1
BYSI
BeyondSpring Inc
11 Jan 22
BeyondSpring Announces Organizational Streamlining
4:50pm
approval process, results that do not meet the Company’s expectations regarding the potential safety, the ultimate efficacy or clinical utility of its
6-K
EX-99.1
BYSI
BeyondSpring Inc
30 Dec 21
Current report (foreign)
12:30pm
or denial in regulatory approval process, results that do not meet our expectations regarding the potential safety, the ultimate efficacy or clinical
6-K
EX-99.1
1tqkzq u4e
1 Dec 21
Current report (foreign)
8:21am
6-K
EX-99.1
c05h2
10 Nov 21
BeyondSpring Appoints Commercial Leader Mark Santos to its Board of Directors
4:05pm
6-K
EX-99.1
at18p bul
21 Sep 21
Current report (foreign)
4:17pm
6-K
EX-99.1
a2fjl q8wiq
10 Sep 21
Current report (foreign)
8:30am
6-K
EX-99.1
deq3 u39aindc6
26 Aug 21
BeyondSpring Announces Exclusive Commercialization and Co-development Agreement with Jiangsu Hengrui Pharmaceuticals for Plinabulin in Greater China
7:15am
6-K
EX-99.1
sgxmv36y web15w
5 Aug 21
Current report (foreign)
1:32pm
6-K
EX-99.1
8b2xtvmju1q2qzcleat
4 Aug 21
Current report (foreign)
7:30am
6-K
EX-99.1
t7uukb5s3jr5nlrys
14 Jul 21
BeyondSpring Strengthens Board with the Addition of Ex-Immunomedics and Constellation Commercial Head Brendan Delaney
7:45am
6-K
EX-99.1
lmf5e0
16 Jun 21
BeyondSpring Announces First Quarter 2021 Financial Results and Provides a Corporate Update
8:36am
6-K
EX-99.1
m25atv101
1 Apr 21
Current report (foreign)
8:22am
6-K
EX-99.1
api6qop nwemhnza
9 Feb 21
Current report (foreign)
9:21am
6-K
EX-99.1
pr62 434at9t
18 Dec 20
BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors
6:01am
424B5
fyts7eorrxqauhu1m1d
19 Nov 20
Prospectus supplement for primary offering
4:12pm
424B5
as4a69ftdeme 6as
17 Nov 20
Prospectus supplement for primary offering
4:19pm